Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.08−0.01 (-0.48%)
Close on Nov 16, 2026Market cap $35.46MP/E –Yield –
Veru ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Veru's ebitda for the twelve months ending Jun 30, 2026 was -$19.08M. For fiscal 2025 it was -$24.60M. The highest annual figure on record is $11.40M in fiscal 2012.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$24.60M | – |
| FY2024 | Sep 30, 2024 | -$35.90M | – |
| FY2023 | Sep 30, 2023 | -$93.51M | – |
| FY2018 | Sep 30, 2018 | -$20.70M | – |
| FY2017 | Sep 30, 2017 | -$8.16M | -337.1% |
| FY2016 | Sep 30, 2016 | $3.44M | -51.6% |
| FY2015 | Sep 30, 2015 | $7.11M | +57.6% |
| FY2014 | Sep 30, 2014 | $4.51M | -56.4% |
| FY2013 | Sep 30, 2013 | $10.35M | -9.3% |
| FY2012 | Sep 30, 2012 | $11.40M | +203.2% |
| FY2011 | Sep 30, 2011 | $3.76M | -21.9% |
| FY2010 | Sep 30, 2010 | $4.82M | -3.4% |
| FY2009 | Sep 30, 2009 | $4.99M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$7.69M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$7.19M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$5.40M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $1.20M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$7.52M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$8.09M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$10.18M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$9.28M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$10.48M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$8.82M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$7.32M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$8.11M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$969.17K | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$3.73M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$4.92M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$4.65M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$7.39M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$2.71M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$1.18M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$2.49M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$1.79M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$197.75K | – |
See a number that looks wrong?